Cancer Screening Training for Academics

NCT07253792 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2025-11-28

No results posted yet for this study

Summary

Purpose: The purpose of this research is to examine the effect of cancer screening education on individuals' knowledge levels regarding cancer screening and their rates of utilization of primary health care services.

Method: The research was conducted using a parallel group pretest-posttest experimental design. The study, conducted at a foundation university between April and May 2025, included 71 academics selected using simple random sampling. The intervention group received structured cancer screening education for four weeks. Data will be collected using a Personal Information Form and the Cancer Screening Knowledge Scale (CSKS), and will be analyzed using appropriate statistical methods.

Conditions

Interventions

BEHAVIORAL

Cancer training

Pre-test data, including the Personal Information Form and the Cancer Screening Information Scale, were collected from participants in the intervention group before the training began. The pre-test took approximately 5-10 minutes to complete. Subsequently, this group received training on cancer screening and Family Health Centre use once a week for a total of four weeks. Following the completion of the training, a post-test was administered at the end of the fourth week.

Sponsors & Collaborators

  • KTO Karatay University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-05-01
Completion
2025-05-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07253792 on ClinicalTrials.gov